Illumina awarded NIH funding for COVID-19 test that runs 3,000 samples at once
Excerpt from the Article:
San Diego gene sequencing giant Illumina has secured government funding for a COVID-19 test that can detect the novel coronavirus in thousands of samples at once, according to an announcement this week from the National Institutes of Health.
The NIH awarded nine companies a total of $129 million to develop rapid, efficient COVID-19 tests. Illumina’s chief medical officer, Dr. Phil Febbo, would not disclose the exact amount the company will receive. But he says the funding will aid the company’s efforts over the next few months to test 48,000 samples a day for the coronavirus.
Click the button below to continue reading the Article:
Discover What Sets TrialStat Apart From Ordinary Data Management
Click the image or button below to explore our interactive infographic which illustrates the comprehensive and unique capabilities of the TrialStat eClinical Suite.
Request Your Demo Today!
From rapid database build through database lock, we deliver consistent quality on-time and on-budget. Ready to upgrade your eClinical toolkit?